跳至主要内容
临床试验/ACTRN12612000367842
ACTRN12612000367842招募中4 期

Proof of concept to determine the feasibility of single dose liposomal Amphotericin B for the treatment of Visceral Leishmaniasis patients at Upazila level in Bangladesh

World Health Organization0 个研究点目标入组 300 人开始时间: 2012年3月30日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
5 Years 至 o limit(—)
性别
All

入选标准

  • Male or female patients 5 or more years of age
  • History of fever for more than 2 weeks
  • Splenomegaly
  • rK 39 rapid test positive done by the study team
  • Hemoglobin equal or greater than 5 g/dl

排除标准

  • A history of intercurrent or presence of clinical signs / symptoms of concurrent diseases / conditions not under control before starting the treatment with liposomal amphotericin B (AmBisme).
  • Any condition which according to the investigator might prevent the patient from completing the study therapy and subsequent follow up
  • A history of allergy or hypersensitivity to amphotericin B
  • Previous treatment for VL within two months of enrolment into the study
  • Prior treatment failure with amphotericin B

研究者

相似试验

Feasibility of using single dose liposomal... | 临床试验